Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
J Med Chem ; 65(1): 191-216, 2022 01 13.
Article in English | MEDLINE | ID: mdl-34928144

ABSTRACT

Targeted concurrent inhibition of intestinal drug efflux transporter P-glycoprotein (P-gp) and drug metabolizing enzyme cytochrome P450 3A4 (CYP3A4) is a promising approach to improve oral bioavailability of their common substrates such as docetaxel, while avoiding side effects arising from their pan inhibitions. Herein, we report the discovery and characterization of potent small molecule inhibitors of P-gp and CYP3A4 with encequidar (minimally absorbed P-gp inhibitor) as a starting point for optimization. To aid in the design of these dual inhibitors, we solved the high-resolution cryo-EM structure of encequidar bound to human P-gp. The structure guided us to prudently decorate the encequidar scaffold with CYP3A4 pharmacophores, leading to the identification of several analogues with dual potency against P-gp and CYP3A4. In vivo, dual P-gp and CYP3A4 inhibitor 3a improved the oral absorption of docetaxel by 3-fold as compared to vehicle, while 3a itself remained poorly absorbed.


Subject(s)
ATP Binding Cassette Transporter, Subfamily B, Member 1/antagonists & inhibitors , Cryoelectron Microscopy/methods , Cytochrome P-450 CYP3A Inhibitors/pharmacology , Cytochrome P-450 CYP3A/chemistry , Drug Design , Drug Discovery , Enzyme Inhibitors/pharmacology , Administration, Oral , Animals , Antineoplastic Agents/administration & dosage , Cytochrome P-450 CYP3A Inhibitors/chemistry , Docetaxel/administration & dosage , Enzyme Inhibitors/chemistry , Humans , Mice
2.
Eur J Med Chem ; 125: 975-991, 2017 Jan 05.
Article in English | MEDLINE | ID: mdl-27816890

ABSTRACT

Understanding subtle aspects of hydrogen bonding is a challenging but crucial task to improve our ability to design ligands with high affinity for protein hosts. To gain a deeper understanding of these aspects, we investigated a series of thrombin inhibitors in which the basicity of the ligand's group that accepts an H-bond from Gly216 was modulated via bioisosterism; e.g., a C=O acceptor was made electron deficient or rich via bioisosteric replacements of the adjacent moiety. Although the ligand's binding affinity was anticipated to improve when the H-bond basicity is increased (due to stronger H-bonding with the protein), we herein present data that unexpectedly revealed an opposite trend. This trend was attributed to a dominating role played by desolvation in determining the relative binding affinity. For example, a decrease in the H-bond basicity reduces the desolvation penalty and, as experimentally observed, improves the binding affinity, given that the reduction in the desolvation penalty dominates the change in the net contribution of the ligand's interactions with the protein. The current study, therefore, reveals that desolvation can be a major underlying cause for the apparently counterintuitive structure-activity relationship (SAR) outcomes, and indicates that understanding this factor can improve our ability to predict binding affinity and to design more potent ligands.


Subject(s)
Enzyme Inhibitors/metabolism , Solvents/pharmacology , Thrombin/metabolism , Animals , Humans , Hydrogen Bonding , Ligands , Protein Binding/drug effects , Structure-Activity Relationship , Thrombin/antagonists & inhibitors
3.
Eur J Med Chem ; 90: 897-915, 2015 Jan 27.
Article in English | MEDLINE | ID: mdl-25559080

ABSTRACT

Predicting how binding affinity responds to ligand structural modifications in structure-activity relationship studies (SAR) is a major challenge in medicinal chemistry. This is particularly true when two or more of these modifications are carried out simultaneously. In this study, we present binding affinity data from several series of thermolysin inhibitors in which simultaneous structural modifications were investigated to determine whether they are cooperative or additive. Data revealed that, while additivity is at work in some cases, cooperativity is more commonly demonstrated. Cooperativity and additivity were then correlated with ligand descriptors, such as the spacing and the topological features of the modified groups, in a manner that may provide guidance as to when each model should be utilized. Cooperativity was particularly associated with contiguous groups and small unbranched hydrophobic side chain. Additivity, on the other hand, was associated with moderately distant hydrophobic group combinations and side chain branching. Such correlations can improve the predictability of SAR studies and can provide a starting point for additional investigations that may lead to further significant enhancements in the current scoring functions.


Subject(s)
Matrix Metalloproteinase Inhibitors/pharmacology , Thermolysin/antagonists & inhibitors , Ligands , Matrix Metalloproteinase Inhibitors/chemistry , Models, Molecular , Structure-Activity Relationship , Thermodynamics , Thermolysin/metabolism
4.
J Med Chem ; 57(6): 2315-33, 2014 Mar 27.
Article in English | MEDLINE | ID: mdl-24479949

ABSTRACT

The thermodynamic consequences of systematic modifications in a ligand side chain that binds in a shallow hydrophobic pocket, in the presence and absence of a neighboring ligand carboxylate group, were evaluated using isothermal titration calorimetry (ITC). Data revealed that the carboxylate significantly changes the relative thermodynamic signatures of these modifications, likely via altering the H-bonding/organization status of the hydration waters both in the unbound and the bound states. This carboxylate group was found to be proenthalpic, antientropic in some cases, and antienthalpic, proentropic in others. A remarkable enthalpy-entropy compensation relationship was also observed, reflecting the fact that the hydrophobic effect is governed by the thermodynamic status of the associated aqueous environment. This study could improve our understanding of the hydrophobic effect and may enhance our ability to design potent ligands that are capable of modulating biological processes.


Subject(s)
Hydrogen Bonding , Protein Binding/physiology , Binding Sites , Calorimetry , Crystallography, X-Ray , Entropy , Indicators and Reagents , Ligands , Models, Molecular , Protein Structure, Tertiary , Thermodynamics
6.
J Med Chem ; 55(19): 8283-302, 2012 Oct 11.
Article in English | MEDLINE | ID: mdl-22894131

ABSTRACT

Ligand functional groups can modulate the contributions of one another to the ligand-protein binding thermodynamics, producing either positive or negative cooperativity. Data presented for four thermolysin phosphonamidate inhibitors demonstrate that the differential binding free energy and enthalpy caused by replacement of a H with a Me group, which binds in the well-hydrated S2' pocket, are more favorable in presence of a ligand carboxylate. The differential entropy is however less favorable. Dissection of these differential thermodynamic parameters, X-ray crystallography, and density-functional theory calculations suggest that these cooperativities are caused by variations in the thermodynamics of the complex hydration shell changes accompanying the H→Me replacement. Specifically, the COO(-) reduces both the enthalpic penalty and the entropic advantage of displacing water molecules from the S2' pocket and causes a subsequent acquisition of a more enthalpically, less entropically, favorable water network. This study contributes to understanding the important role water plays in ligand-protein binding.


Subject(s)
Thermolysin/antagonists & inhibitors , Thermolysin/chemistry , Water/chemistry , Bacillus/chemistry , Calorimetry , Carboxylic Acids/chemical synthesis , Carboxylic Acids/chemistry , Crystallography, X-Ray , Hydrophobic and Hydrophilic Interactions , Ligands , Models, Molecular , Molecular Structure , Mutation , Organophosphonates/chemical synthesis , Organophosphonates/chemistry , Protein Binding , Stereoisomerism , Thermodynamics , Thermolysin/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...